Smoking History Predicts for Increased Risk of Second Primary Lung Cancer: A Comprehensive Analysis

被引:46
|
作者
Boyle, John M. [1 ]
Tandberg, Daniel J. [1 ]
Chino, Junzo P. [1 ]
D'Amico, Thomas A. [2 ]
Ready, Neal E. [3 ]
Kelsey, Chris R. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Div Cardiothorac Surg, Dept Surg, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Div Med Oncol, Dept Med, Durham, NC 27710 USA
关键词
second primary lung cancer; lung cancer; smoking; survival; smoking cessation; LONG-TERM SURVIVAL; NEVER-SMOKERS; LOCAL RECURRENCE; RESECTION; CESSATION; TUMORS;
D O I
10.1002/cncr.29095
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUNDTobacco use is the most important risk factor for the development of lung cancer. The objective of the current study was to determine the effect of smoking on the development of second primary lung cancers (SPLCs) and other clinical outcomes after surgery for non-small cell lung cancer (NSCLC). METHODSAll patients who underwent surgery for NSCLC at the study institution from 1995 through 2008 were identified. Rates of SPLC were analyzed based on smoking status and pack-year exposure. Multivariate analysis was performed to determine risk factors for SPLC. Overall survival, local control, distant metastases, and postoperative mortality were also examined. RESULTSA total of 1484 patients were identified, including 98 never-smokers. The incidence of SPLC at 3 years, 5 years, and 8 years was 5%, 8%, and 16%, respectively. Only 1 never-smoker developed an SPLC. On multivariate analysis, which was restricted to ever-smokers with pack-years as a continuous variable, smoking history was found to be the only independent risk factor for SPLC (hazard ratio, 1.08; 95% confidence interval, 1.02-1.16 [P=.031]), corresponding to an 8% increased risk per 10 pack-year exposure. There were no differences in rates of local control or distant metastases based on smoking status. There was a trend toward lower postoperative mortality in never-smokers compared with ever-smokers (0% vs 3.3%; P=.069). Overall survival was found to be significantly worse for current smokers compared with former and never-smokers. CONCLUSIONSSPLCs are rare in never-smokers. Increasing tobacco exposure is associated with a higher risk of SPLC in patients with a history of smoking. Current smokers have an increased risk of mortality whereas former and never-smokers have comparable survival. Cancer 2015;121:598-604. (c) 2014 American Cancer Society. The current study identifies and quantifies risk factors for second primary lung cancer in a population of patients treated for an index non-small cell lung cancer. Among 1484 subjects, it was found that smoking was the only risk factor assessed that predicted for the development of a second primary lung cancer, with never-smokers having an exceedingly low risk.
引用
收藏
页码:598 / 604
页数:7
相关论文
共 50 条
  • [31] A Retrospective Analysis Comparing VATS Cost Discrepancies and Outcomes in Primary Lung Cancer vs. Second Primary Lung Cancer Patients
    Tanase, Bogdan Cosmin
    Burlacu, Alin Ionut
    Nistor, Claudiu Eduard
    Horvat, Teodor
    Oancea, Cristian
    Marc, Monica
    Tudorache, Emanuela
    Mateescu, Tudor
    Manolescu, Diana
    HEALTHCARE, 2023, 11 (12)
  • [32] Metabolomic Profiling for Second Primary Lung Cancer Among Lung Cancer Survivors
    Han, S.
    Su, L.
    Diao, N.
    Christiani, D.
    Wakelee, H.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S567 - S567
  • [33] Risk of second primary lung cancer in women after radiotherapy for breast cancer
    Grantzau, Trine
    Thomsen, Mette Skovhus
    Vaeth, Michael
    Overgaard, Jens
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 (03) : 366 - 373
  • [34] Smoking and alcohol drinking effect on radiotherapy associated risk of second primary cancer and mortality among breast cancer patients
    DiMarzio, Paola
    Peila, Rita
    Dowling, Oonagh
    Timony, Dennis M.
    Balgobind, Amrita
    Lee, Lucille N.
    Kostroff, Karen M.
    Ho, Gloria Y. F.
    CANCER EPIDEMIOLOGY, 2018, 57 : 97 - 103
  • [35] Incidence of Smoking-Related Second Primary Cancers After Lung Cancer in Germany: An Analysis of Nationwide Cancer Registry Data
    Eberl, Marian
    Tanaka, Luana F.
    Kraywinkel, Klaus
    Klug, Stefanie J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (03) : 388 - 398
  • [36] Surgical Treatment for Metachronous Second Primary Lung Cancer after Radical Resection of Primary Lung Cancer
    Ishigaki, Takahiko
    Yoshimasu, Tatsuya
    Oura, Shoji
    Ota, Fuminori
    Nakamura, Rie
    Hirai, Yoshimitu
    Okamura, Yoshitaka
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 19 (05) : 341 - 344
  • [37] A Comprehensive Analysis of Tobacco Smoking History as a Risk for Outcomes after Endoscopic Transsphenoidal Resection of Pituitary Adenoma
    Min, Susie
    Zhang, Grace
    Hu, Alex
    Petito, Gabrielle T. T.
    Tripathi, Siddhant H. H.
    Shukla, Geet
    Kumar, Adithya
    Shah, Sanjit
    Phillips, Katie M. M.
    Forbes, Jonathan A. A.
    Zuccarello, Mario
    Andaluz, Norberto O. O.
    Sedaghat, Ahmad R. R.
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2024, 85 (03) : 255 - 260
  • [38] Vitamin D and Lung Cancer Risk: A Comprehensive Review and Meta-Analysis
    Zhang, Liqun
    Wang, Sihai
    Che, Xiaoyu
    Li, Xuehui
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 36 (01) : 299 - 305
  • [39] Second pulmonary resection for a second primary lung cancer: analysis of morbidity and survival
    Abid, Walid
    Seguin-Givelet, Agathe
    Brian, Emmanuel
    Grigoroiu, Madalina
    Girard, Philippe
    Girard, Nicolas
    Gossot, Dominique
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2021, 59 (06) : 1287 - 1294
  • [40] Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer
    Choi, Eunji
    Sanyal, Nilotpal
    Ding, Victoria Y.
    Gardner, Rebecca M.
    Aredo, Jacqueline, V
    Lee, Justin
    Wu, Julie T.
    Hickey, Thomas P.
    Barrett, Brian
    Riley, Thomas L.
    Wilkens, Lynne R.
    Leung, Ann N.
    Le Marchand, Loic
    Tammemagi, Martin C.
    Hung, Rayjean J.
    Amos, Christopher, I
    Freedman, Neal D.
    Cheng, Iona
    Wakelee, Heather A.
    Han, Summer S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (01): : 87 - 96